EirGenix is a global biologics CDMO and biosimilar developer delivering high quality, cost competitive solutions from early development through commercial manufacturing
EirGenix is a global biologics CDMO and biosimilar developer delivering high quality, cost competitive solutions from early development through commercial manufacturing. Founded in 2012, we support pharmaceutical and biotechnology partners worldwide with fully integrated services spanning cell line development, process development, analytical testing, cGMP manufacturing, and ADC development.